Cointime reports: China A-share innovative drug concept stocks swung lower on Thursday, with Baicheng Pharma plunging more than 15%. Guilin Sanjin briefly hit the daily limit-down, while Asymchem, CSPC Jingfeng, Liuzhou Pharmaceutical and Allist Pharmaceuticals also declined. The pullback follows a volatile session for the sector, though no specific catalyst was cited in the market move.
China A-share Innovative Drug Concept Stocks Retreat; Baicheng Pharma Plunges Over 15%
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
15m ago
Alibaba’s T-Head Said to Plan Hong Kong IPO Next Year, Targeting $2-3B
30m ago
Musk: Cybertruck orders far exceed production
34m ago
Foreign investors net bought record $1.47T in US stocks and corporate bonds over 12 months
1h ago
South Korea’s KOSPI closes down 0.81% at 5,018.85, lowest since February
3h ago
Citi: US Midterms May Slow AI Spending, Rotate Flows to India Stocks
5h ago
Unitree Robotics Market Cap Tops 300B Yuan Intraday